Abbott Laboratories will divest its eye care division to Johnson & Johnson for about $4.33 billion in cash, reported Reuters. Here are five things to know about the deal. Abbott, which recently ...

Abbott (ABT) ended the recent trading session at $109.95, demonstrating a +1.78% change from the preceding day's closing price. This move outpaced the S&P 500's daily gain of 1.01%. Meanwhile, the Dow ...

Abbott Park, Ill.-based Abbott Laboratories and Saint Paul, Minn.-based St. Jude Medical — which Abbott is in the process of acquiring for $25 billion — plan to sell several medical devices to ...

Abbott reported strong sales for its vascular medical devices business, which posted double-digit growth during 2009 and rose 9.1 percent to $723 million during the fourth quarter, including the ...

The Federal Trade Commission approved Abbott Park, Ill.-based Abbott Laboratories’ proposed acquisition of Little Canada, Minn.-based St. Jude Medical for $25 billion. Here’s what you should know. 1.

After providing life-saving occluders to several canines and kids with patent ductus arteriosus, medical device Abbott set up ...